Durable Response with Immunotherapy Combos in NSCLC with Brain Metastases

(MedPage Today) -- Combination nivolumab (Opdivo) and ipilimumab (Yervoy) with chemotherapy offered a durable survival benefit versus chemotherapy alone in advanced non-small cell lung cancer (NSCLC) with brain metastases, according to an analysis...